HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women

Journal of Experimental Medicine

Volumn 185, Issue 2, 1997, Pages 293-303

  Musey, Luwy ^a   Hu, Yuxiang ^a   Eckert, Linda ^a   Christensen, Michael ^a   Karchmer, Tobi ^a   McElrath, M Juliana ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; EPITOPE MAPPING; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTIC INFILTRATION; MOLECULAR CLONING; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UTERINE CERVICITIS; UTERINE CERVIX MUCOSA; VIRUS EXPRESSION;

CELL LINE, TRANSFORMED; CERVIX UTERI; EPITOPES; FEMALE; GENE PRODUCTS, ENV; HIV INFECTIONS; HIV-1; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; PHENOTYPE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031047593     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.2.293     Document Type: Article

References (38)

1. Mertens, T.E., and A. Burton. 1996. Estimates and trends of the HIV/AIDS epidemic. AIDS. 10(Suppl. A):S221-S228.
2. Kutteh, W.H., R.P. Edwards, A.C. Menge, and J. Mestecky. 1993. IgA immunity in female reproductive tract secretions. In Local Immunity in Reproduction Tract Tissues. Oxford University Press. 229-243.
3. McGhee, J.R., and J. Mestecky. 1992. The mucosal immune system in HIV infection and prospects for mucosal immunity to AIDS. In AIDS Research Review. 2:289-312.
4. Nielsen, K., P. Boyer, M. Dillon, D. Wafer, L.S. Wei, E. Garratty, R.E. Dickover, and Y.J. Bryson. 1996. Presence of human immunodeficiency virus (HIV) type 1 and HIV-1-specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infants. J Infect. Dis. 173:1001-1004.
5. Kozlowski, P.A., K.P. Black, L. Shen, and S. Jackson. 1995. High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. Masking by IgG. J Immunol. 154:6163-6173.
6. Janoff, E.N., S.M. Wahl, K. Thomas, and P.D. Smith. 1995. Modulation of human immunodeficiency virus type 1 infection of human monocytes by IgA. J. Infect. Dis. 172:855-858.
7. Lohman, B.L., C.J. Miller, and M.B. McChesney. 1995. Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J. Immunol. 155:5855-5860.
8. Moscicki, A.-B., S.D. Hunter, S. Garland, M. Quinn, S.M. Crowe, K. Shortman, and D. Stites. 1995. A simple method for the propagation of cervical lymphocytes. Clin. Diag. Lab. Immunol. 2:40-43.
9. Crowley-Nowick, P.A., M. Bell, R.P. Edwards, D. McCallister, H. Gore, A. Kanbour-Shakir, J. Mestecky, and E.E. Partridge. 1995. Normal uterine cervix: characterization of isolated lymphocyte phenotypes and immunoglobulin secretion. Am. J. Reprod. Immunol. 34:241-247.
10. Hussain, L.A., C.G. Kelly, R. Fellowes, E.M. Hecht, J. Wilson, M. Chapman, and T. Lehner. 1992. Expression and gene transcript of Fc receptors tor IgG, HLA class II antigens and Langerhans cells in human cervico-vaginal epithelium. Clin. Exp. Immunol. 90:530-538.
11. McKenzie, J., A. King, J. Hare, T. Fulford, B. Wilson, and M. Stanley. 1991. Immunocytochemical characterization of large granular lymphocytes in normal cervix and HPV associated disease. J. Pathol. 165:75-80.
12. Poppe, W.A.J., P.S. Ide, M.P.G. Drijkoningen, J.M. Lauweryns, and F.A. Van Assche. 1995. Tobacco smoking impairs the local immunosurveillance in the uterine cervix. Gynecol. Obstet. Invest. 39:34-38.
13. Garzetti, G.G., A. Ciavaettini, L. Butini, A. Vecchi, and M. Montroni. 1995. Cervical dysplasia in HIV-seropositive women: role of human papillomavirus infection and immune status. Gynecol. Obstet. Invest. 40:52-56.
14. Fukuda, K., T. Hachisuga, S. Nakamura, N. Matsuo, T. Iwasaka, and H. Sugimori. 1993. Local immune response in persistent cervical dysplasia. Obstet. Gyn. 82:941-945.
15. + lymphocytes are recruited to neoplastic cervix. J. Clin. Immunol. 15:130-136.
16. Olaitan, A., M.A. Johnson, A. MacLean, and L.W. Poulter. 1996. The distribution of immunocompetent cells in the genital tract of HIV-positive women. AIDS (Phila). 10:759-764.
17. Earl, P.L., A.W. Hugin, and B. Moss. 1990. Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression of a recombinant vaccinia virus. J. Virol. 64:2448-2451.
18. Earl, P.L., S. Koenig, and B. Moss. 1991. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of protein with truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 65:31-41.
19. Flexner, C., S.S. Broyles, P. Earl, S. Chakrabarti, and B. Moss. 1988. Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses. Virology. 166:339-349.
20. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expressing vector: co-expression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
21. McFarland, E.J., T.J. Curiel, D.J. Schoen, M.E. Rosandich, R.T. Schooley, and D.R. Kuritzkes. 1993. Cytotoxic T lymphocyte line specific for the human immunodeficiency virus type 1 gag and reverse transcriptase derived from a vertically infected child. J. Infect. Dis. 167:719-23.
22. McElrath, M.J., M. Rabin, M. Hoffman, S. Klucking, J.V. Garcia, and P.D. Greenberg. 1994. Evaluation of human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte responses utilizing B-lymphoblastoid cell lines transduced with the CD4 gene and infected with HIV-1. J. Virol. 68:5074-5083.
23. Akridge, R.E., L.K.M. Oyafuso, and S.A. Reed. 1994. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol. 153: 5782-5789.
24. + T cells bind very tightly to the restricting class I major histocompatibility complex protein on intact cells but not the purified class I protein. Proc. Natl. Acad. Sci. USA. 88:11276-11278.
25. Hadida, F., A. Parrot, M.P. Kieny, B. Sadat-Sowti, C. Mayaud, P. Debre, and B. Autran. 1992. Carboxyl-terminal and central regions of human immunodeficiency virus-1 nef recognized by cytotoxic T lymphocytes from the lymphoid organs. An in vitro limiting dilution analysis. J. Clin. Invest. 89: 53-60.
26. Jassoy, C., R.P. Johnson, B.A. Navia, J. Worth, and B.D. Walker. 1992. Detection of a vigorous HIV-1 specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J. Immunol. 149:3113-3119.
27. Plata, F., B. Autran, L.P. Martins, S. Wain-Hobson, M. Raphael, C. Mayaud, M. Denis, J.M. Guillon, and P. Debre. 1987. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature (Lond.). 328:348-351.
28. + phenotypes from orally immunized mice provide Th2-like function for B cell responses. J. Immunol. 151:6681-6691.
29. Coleman, N., and M.A. Stanley. 1994. Characterization and functional analysis of the expression of vascular adhesion molecules in human papillomavirus-related disease of the cervix. Cancer (Phila). 74:884-892.
30. Shaw, S.K. and M.B. Brenner. 1995. The beta 7 integrins in mucosal homing and retention. Semin. Immunol. 7:335-342.
31. Brew, R., D.C. West, J. Burthem, and S.E. Christmas. 1995. Expression of the human mucosal lymphocyte antigen, HML-1, by T cells activated with mitogen or specific antigen in vitro. Scand. J. Immunol. 41:553-562.
32. Petry, K.U., D. Scheffel, U. Bode, T. Gabrysiak, H. Kochel, E. Kupsch, M. Glaubitz, S. Niesert, H. Kuhnle, and I. Schedel. 1994. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int. J. Cancer. 57:836-840.
33. Korn, A.P., and D.V. Landers. 1995. Gynecologic disease in women infected with human immunodeficiency virus type 1. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 9:361-370.
34. Maiman, M., R.G. Fruchter, L. Guy, S. Cuthill, P. Levine, and E. Serur. 1993. Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer (Phila). 71:402-406.
35. Powderly, W.G. Resistant candidiasis. 1994. AIDS Res Hum Retroviruses. 10:925-929.
36. Marte, C. 1992. Papanicolaou smear abnormalities in ambulatory care sites for women infected with the human immunodeficiency virus. Am. J. Obstet. Gynecol. 166:1232-1237.
37. Poss, M., H.L. Martin, J.K. Kreiss, L. Granville, B. Chohan, P. Nyange, K. Mandaliya, and J. Overbaugh. 1995. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J. Virol. 69:8118-8122.
38. Moskophidis, D., F. Lechner, H. Pircher, and R.M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature (Lond.). 362:758-761.